Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxlovid in Long COVID (PAX LC)
NCT05668091Phase 2Completed
- Start
- Apr 2023
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Nirmatrelvir in post-COVID-19 condition (PCC). Started Apr 2023; status: completed.
02
Drugs
Nirmatrelvir
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT05668091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05668091.